Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Glucose Sensor Use for Type 2 Diabetes Self-Care in Young Adults

Tests a glucose sensor worn for 30 days by young adults with type 2 diabetes.

Plain-language title generated from the registry record
Registry title: Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults

Key facts

Where
San Diego, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 45 years old?

Source: NCT07065721, who can take part

Where in United States

  • Scripps HealthSan Diego, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
San Diego State University
Trial code
NCT07065721
Record updated
9 November 2026
Original description
Type 2 diabetes in increasing common in young adults. Utilizing a mixed-methods, community-based approach, this study offers continuous glucose monitors (CGMs) to young adults with type 2 diabetes for 30 days, and collects both quantitative and qualitative data to understand barriers and facilitators of CGM use, participants' changes in awareness of glucose patterns while using the CGM, and preferences for a CGM-based self-management intervention.Read full original descriptionShow less

CAPAZ-2D: Continuous Glucose Monitoring to Augment and Personalize Self-Management of Type 2 Diabetes in Hispanic/Latinx Young Adults

Type 2 diabetes in increasing common in young adults. Utilizing a mixed-methods, community-based approach, this study offers continuous glucose monitors (CGMs) to young adults with type 2 diabetes for 30 days, and collects both quantitative and qualitative data to understand barriers and facilitators of CGM use, participants' changes in awareness of glucose patterns while using the CGM, and preferences for a CGM-based self-management intervention.

Inclusion: adult 18-45 years of age; diagnosis of type 2 diabetes in the last 5 years, as evidenced in the electronic medical record; no prior use or experience with wearable CGMs; possession of a smart phone that is compatible with Dexcom CGM sensors (nearly all smartphones are compatible) and willing to download and utilize the Dexcom CGM app; fluency in English or Spanish.

Exclusion: severe mental illness (e.g., psychosis, suicidal ideation); pregnancy or <6 months postpartum.

ClinicalTrials.gov NCT07065721